Paula A Witt-Enderby
Overview
Explore the profile of Paula A Witt-Enderby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stayduhar J, Covvey J, Schreiber J, Witt-Enderby P
Pharmacy (Basel)
. 2023 Jun;
11(3).
PMID: 37368422
We aimed to collect parallel perspectives from pharmacists and pharmacy students on their use, knowledge, attitudes, and perceptions about herbal supplements/natural products. Two cross-sectional descriptive survey questionnaires-one focusing on pharmacists...
2.
Munmun F, Witt-Enderby P
Methods Mol Biol
. 2022 Sep;
2550:353-364.
PMID: 36180705
Transwell co-cultures are critical to study cell-to-cell communication through the release of factors between different cells allowing for the simultaneous assessment of treatment effects on one cell type (e.g., Cell...
3.
Munmun F, Mohiuddin O, Hoang V, Burow M, Bunnell B, Sola V, et al.
J Pineal Res
. 2022 Jun;
73(2):e12814.
PMID: 35674448
Melatonin, the primary hormone involved in circadian entrainment, plays a significant role in bone physiology. This study aimed to assess the role of MEK1/2 and MEK5 in melatonin-mediated actions in...
4.
Abdelmalek C, Hu Z, Kronenberger T, Kublbeck J, Kinnen F, Hesse S, et al.
J Med Chem
. 2022 Mar;
65(6):4616-4632.
PMID: 35286086
Anticancer drug conjugates may benefit from simultaneous action at two targets potentially overcoming the drawbacks of current cancer treatment, such as insufficient efficacy, high toxicity, and development of resistance. Compared...
5.
Goldman R, Bongiorno P, Olcese J, Witt-Enderby P, Shatkin J
Pediatr Ann
. 2021 Sep;
50(9):e391-e395.
PMID: 34542334
Occasional sleeplessness in children is common, with as many as 25% of all healthy children experiencing a problem sleeping at some point over the course of their childhood. Occasional sleeplessness...
6.
Munmun F, Witt-Enderby P
J Pineal Res
. 2021 Jun;
71(1):e12749.
PMID: 34085304
Melatonin is the primary circadian output signal from the brain and is mainly synthesized in pinealocytes. The rhythm and secretion of melatonin are under the control of an endogenous oscillator...
7.
Hasan M, Browne E, Guarinoni L, Darveau T, Hilton K, Witt-Enderby P
Breast Cancer (Auckl)
. 2020 Jul;
14:1178223420924634.
PMID: 32636633
A novel melatonin, estrogen, and progesterone hormone therapy was developed as a safe bio-identical alternative hormone therapy for menopausal women based on the Women's Health Initiative findings that PremPro™ increased...
8.
Boutin J, Witt-Enderby P, Sotriffer C, Zlotos D
J Pineal Res
. 2020 Jun;
69(3):e12672.
PMID: 32531076
Melatonin MT and MT receptor ligands have been vigorously explored for the last 4 decades. Inspection of approximately 80 publications in the field revealed that most melatonergic ligands were structural...
9.
Dodda B, Bondi C, Hasan M, Clafshenkel W, Gallagher K, Kotlarczyk M, et al.
Front Oncol
. 2019 Jul;
9:525.
PMID: 31355130
Melatonin has numerous anti-cancer properties reported to influence cancer initiation, promotion, and metastasis. With the need for effective hormone therapies (HT) to treat menopausal symptoms without increasing breast cancer risk,...
10.
Hasan M, Marzouk M, Adhikari S, Wright T, Miller B, Matossian M, et al.
Mol Pharmacol
. 2019 Jun;
96(2):272-296.
PMID: 31221824
Tamoxifen is used to prevent and treat estrogen receptor-positive (ER+) breast cancer (BC); however, its chronic use can increase uterine cancer risk and induce tamoxifen resistance. Novel melatonin-tamoxifen drug conjugates...